A detailed history of Sather Financial Group Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sather Financial Group Inc holds 7,167 shares of MRK stock, worth $690,253. This represents 0.06% of its overall portfolio holdings.

Number of Shares
7,167
Previous 7,451 3.81%
Holding current value
$690,253
Previous $922,000 11.82%
% of portfolio
0.06%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$111.15 - $128.97 $31,566 - $36,627
-284 Reduced 3.81%
7,167 $813,000
Q4 2023

Jan 26, 2024

SELL
$100.18 - $109.02 $200,360 - $218,040
-2,000 Reduced 21.16%
7,451 $812,000
Q3 2023

Oct 19, 2023

SELL
$102.95 - $114.33 $24,090 - $26,753
-234 Reduced 2.42%
9,451 $972,000
Q4 2022

Jan 20, 2023

SELL
$87.44 - $112.11 $13,553 - $17,377
-155 Reduced 1.58%
9,685 $0
Q1 2022

Apr 29, 2022

BUY
$73.51 - $82.4 $364,242 - $408,292
4,955 Added 101.43%
9,840 $807,000
Q3 2021

Nov 02, 2021

BUY
$71.68 - $78.83 $350,156 - $385,084
4,885 New
4,885 $367,000
Q2 2021

Jul 14, 2021

SELL
$70.31 - $77.77 $196,868 - $217,756
-2,800 Closed
0 $0
Q1 2021

Apr 22, 2021

BUY
$68.86 - $81.11 $192,808 - $227,108
2,800 New
2,800 $216,000
Q2 2020

Aug 05, 2020

SELL
$70.42 - $80.13 $391,394 - $445,362
-5,558 Closed
0 $0
Q1 2020

May 11, 2020

SELL
$63.36 - $87.82 $25,407 - $35,215
-401 Reduced 6.73%
5,558 $427,000
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $182,778 - $206,244
2,356 Added 65.39%
5,959 $541,000
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $274,116 - $298,796
3,603 New
3,603 $303,000
Q3 2017

Nov 14, 2017

SELL
$58.67 - $63.13 $319,751 - $344,058
-5,450 Closed
0 $0
Q2 2017

Aug 15, 2017

BUY
N/A
5,450
5,450 $349,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Sather Financial Group Inc Portfolio

Follow Sather Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sather Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sather Financial Group Inc with notifications on news.